Investors have a limited window left to buy Acer Therapeutics Inc. (ACER) – Invest Chronicle

Investors have a limited window left to buy Acer Therapeutics Inc. (ACER)

Acer Therapeutics Inc. (ACER) is priced at $1.39 after the most recent trading session. At the very opening of the session, the stock price was $1.68 and reached a high price of $1.69, prior to closing the session it reached the value of $1.76. The stock touched a low price of $1.37.Recently in News on June 21, 2022, Acer Therapeutics Announces Promotion of Tanya Hayden to Chief Operating Officer. Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, today announced the promotion of Tanya Hayden to Chief Operating Officer (COO). Harry S. Palmin, who had been serving as the Company’s Chief Operating Officer as well as its Chief Financial Officer, will continue to serve as the Company’s Chief Financial Officer. You can read further details here

Acer Therapeutics Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $3.7700 on 04/04/22, with the lowest value was $1.3700 for the same time period, recorded on 06/21/22.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


Acer Therapeutics Inc. (ACER) full year performance was -50.18%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Acer Therapeutics Inc. shares are logging -63.13% during the 52-week period from high price, and -17.26% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.68 and $3.77.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 655922 for the day, which was evidently higher, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Acer Therapeutics Inc. (ACER) recorded performance in the market was -39.04%, having the revenues showcasing -49.64% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 25.03M, as it employees total of 35 workers.

Specialists analysis on Acer Therapeutics Inc. (ACER)

During the last month, 2 analysts gave the Acer Therapeutics Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 2.3297, with a change in the price was noted -0.59. In a similar fashion, Acer Therapeutics Inc. posted a movement of -29.80% for the period of last 100 days, recording 339,056 in trading volumes.

Trends and Technical analysis: Acer Therapeutics Inc. (ACER)

Raw Stochastic average of Acer Therapeutics Inc. in the period of last 50 days is set at 1.37%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 1.37%. In the last 20 days, the company’s Stochastic %K was 1.07% and its Stochastic %D was recorded 1.87%.

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -39.04%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -35.35%, alongside a downfall of -50.18% for the period of the last 12 months. The shares increased approximately by -24.46% in the 7-day charts and went up by -34.74% in the period of the last 30 days. Common stock shares were lifted by -49.64% during last recorded quarter.

Leave a Comment

Your email address will not be published.

On Key

Related Posts